AI Strategy & Readiness Assessment for Pharmaceutical & Biotech
Pharmaceutical & Biotech
AI Strategy & Readiness Assessment
Prioritise high-value AI opportunities while protecting patients, scientific integrity, intellectual property and regulatory confidence.
Turn AI ambition into a governed delivery plan
Prioritise high-value AI opportunities while protecting patients, scientific integrity, intellectual property and regulatory confidence.
Opportunity - Where AI could create structured value
Accelerate research
Support literature intelligence, target discovery, knowledge retrieval and scientific collaboration.
Improve clinical development
Explore protocol design, trial feasibility, site selection, patient recruitment and operational insight.
Strengthen safety and quality
Identify opportunities across pharmacovigilance, quality events, document review and regulated reporting.
Optimise manufacturing
Use operational data to improve yield, maintenance, deviation investigation and supply resilience.
Enable medical teams
Improve controlled access to approved evidence, content and internal knowledge.
Reduce administrative burden
Automate repeatable work while preserving review, traceability and accountable decisions.
Why strategy must come before scale
Your APPTechnology-led assessment helps you navigate the hurdles, pitfalls and signposts needed to get your AI journey right.
- Evidence
Validation and traceability - Data
Privacy and purpose limitation - Reliability
Provenance and expert review - IP
Ownership and model controls
Designed around your operating environment
No AI use case or industry requirement is the same. This assessment incorporates the scientific, regulatory, data and governance requirements of pharmaceutical and biotech organisations.
Move quickly where risk is low. Build evidence where consequences are higher.
From AI ambition to an investable delivery roadmap
A credible starting point before committing data, budget or regulated operations.
How the assessment works
- Align leadership
Establish strategic objectives, intended outcomes and the decisions AI should improve. - Prioritise use cases
Compare value, feasibility, risk, data dependence, organisational impact and commercial value. - Review today’s data view
Discuss known sources, ownership, quality, access, sensitivity and validation needs. - Define guardrails
Set governance, security, human oversight and sector controls for each use case. - Build the roadmap
Sequence quick wins, validation activity, foundations and longer-term initiatives. - Size priority projects
Outline scope, outcomes, stages, skills, technology, timescales and indicative budget. - Review advanced AI requirements
Consider agentic, physical, sovereign or domain-specific implications for operations, data, hardware and governance.
Want to know more?
Visit our AI Strategy & Readiness page for everything you need to know: the assessment at a glance, how it works, what you receive, how AI creates measurable value, the risks of having no AI strategy and a complete FAQ.
Assessment Outputs - What your leadership receives
- Priority portfolio
Ranked use cases linked to scientific, operational and commercial value. - Governance view
Oversight, evidence, data protection and validation requirements. - Phased roadmap
Quick wins, enabling foundations and longer-term regulated initiatives. - Project sizing
Indicative scope, resources, timescales, technology and budget range.
Make AI innovation governable and deliverable
Book an AI Strategy and Enablement Assessment with APPtechnology.
Contact martin.sweeney@apptechnology.co.uk via Microsoft Teams or email to start improving your AI journey.
Open a Teams Chat